Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 63, No. 3, 1996
Issue release date: 1996
Section title: Original Paper
Respiration 1996;63:170–173
(DOI:10.1159/000196539)

The Effect of Diabetes mellitus on the Outcome of Patients with Chronic Obstructive Pulmonary Disease Exacerbated due to Respiratory Infections

Loukides S.a · Polyzogopoulos D.b
aPulmonary Department 401 Army General Hospital, and b4th Department, Athens Chest Hospital ‘Sotiria’, Athens, Greece

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: December 19, 1994
Accepted: August 31, 1995
Published online: January 21, 2009
Issue release date: 1996

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0

ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)

For additional information: http://www.karger.com/RES

Abstract

During the last 2 years, 597 cases of chronic obstructive pulmonary disease (COPD) exacerbated due to respiratory infections were treated in our department. Eighty-eight (14.7%) of them suffered from diabetes mellitus (DM). Thirty-four had insulin-dependent DM and 54 non-insulin-dependent DM. In these groups, we studied the duration of hospitalization, their clinical features, chest X-rays, blood tests (white blood cells, erythrocyte sedimentation rate), blood gases and the sputum culture for bacteria. The paired t test was used for statistical analysis. Our results showed that the mean duration of hospitalization in patients with DM was 10.76 ± 2.7 days (X ± SD), whereas for patients without DM it was 8.53 ± 1.9 days. Patients with insulin-dependent DM had a mean hospitalization of 15.63 ± 3.6 days, which was statistically significant in relation to the group without DM (p < 0.0001). As for the chest X-rays, clinical features, blood tests and blood gases, no statistically significant differences were found among the groups. The sputum culture for bacteria showed that in patients with insulin-dependent DM the isolation of gram-negative bacteria was 51.6%, which was statistically significant in relation to the group without DM, where it was 27.3% (p < 0.0001). In conclusion, a significant percentage of patients with COPD suffers from DM. Patients with insulin-dependent DM and COPD with respiratory infections were found to have longer periods of hospitalization and a larger percentage of gram-negative bacteria in the sputum culture.

© 1996 S. Karger AG, Basel


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: December 19, 1994
Accepted: August 31, 1995
Published online: January 21, 2009
Issue release date: 1996

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0

ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)

For additional information: http://www.karger.com/RES


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.